Shencun Fang

8PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEnergy generation, conversion and storage (excl. chemical and electrical)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 04, 2026
Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial.

|Apr 06, 2026
Furmonertinib combined with bevacizumab in EGFR-TKI-resistant leptomeningeal metastasis: analysis of the CSF ctDNA molecular response and survival outcomes.

Xiaoyue Wang, Yuwen Xie, Jin Hu

|Feb 28, 2026
Radiogenomics in Leptomeningeal Metastasis of Lung Adenocarcinoma: MRI Patterns and Survival Outcomes Following Ommaya Reservoir Chemotherapy.

Yi-Zhen Jia, Yan Zhong, Wen-Hui Shen

|Nov 26, 2025
Extracellular matrix anchored neutrophils drive pulmonary fibrosis in mice.

Liliang Yang, Piaopiao Sun, Jing Wang

|Apr 29, 2025
Furmonertinib in uncommon EGFR-mutated non-small cell lung cancer with central nervous system metastases: A retrospective cohort study.

Yuwen Xie, Hehui Fang, Wanwan Cheng

|Jul 02, 2024
Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer.

Wanwan Cheng, Ting Xu, Lu Yang

Pageof 2

Frequent Collaborators

1 joint publications

Yi-Zhen Jia

1 joint publications

Wen Gao

1 joint publications

Mei Yuan

1 joint publications

Jie Chao